Mental Health Engagement Network (MHEN)

NCT ID: NCT01473550

Last Updated: 2016-03-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mood Disorder Psychotic Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early Intervention

At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.

Group Type EXPERIMENTAL

Access to TELUS Health Space and Smart Phone

Intervention Type BEHAVIORAL

Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.

Later Intervention

A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -\> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.

Group Type EXPERIMENTAL

Access to TELUS Health Space and Smart Phone

Intervention Type BEHAVIORAL

Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Access to TELUS Health Space and Smart Phone

Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
* Able to make informed consent to participate in the study
* Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria

* Younger than 18 or older than 80
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

London Health Sciences Centre

OTHER

Sponsor Role collaborator

Canadian Mental Health Association

OTHER

Sponsor Role collaborator

St. Joseph's Health Care London

OTHER

Sponsor Role collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cheryl Forchuk

Assistant Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cheryl Forchuk, PhD

Role: PRINCIPAL_INVESTIGATOR

Lawson Health Research Institute; University of Western Ontario

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Canadian Mental Health Association (London-Middlesex Branch)

London, Ontario, Canada

Site Status

Regional Mental Health Care

London, Ontario, Canada

Site Status

London Health Sciences Centre

London, Ontario, Canada

Site Status

Western Ontario Therapeutic Community Hostel

London, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Forchuk C, Donelle L, Ethridge P, Warner L. Client Perceptions of the Mental Health Engagement Network: A Secondary Analysis of an Intervention Using Smartphones and Desktop Devices for Individuals Experiencing Mood or Psychotic Disorders in Canada. JMIR Ment Health. 2015 Jan 21;2(1):e1. doi: 10.2196/mental.3926. eCollection 2015 Jan-Mar.

Reference Type DERIVED
PMID: 26543906 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18451

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Loneliness Group Intervention
NCT05619718 ACTIVE_NOT_RECRUITING NA
Implementing Online Mental Health Program
NCT07066943 NOT_YET_RECRUITING NA